|
|
¡ÒâÖé¹·ÐàºÕ¹ Í | 4 | ![](/images/barhorange.gif) | 2.11 |
9789741614424 | 4 | ![](/images/barhorange.gif) | 2.11 |
ÇÔ¸Õ¡ÒÃãªéËéͧÊÁØ´ | 3 | ![](/images/barhorange.gif) | 1.58 |
ÈÙ¹ÂìÇԷºÃÔ¡Òà Í | 3 | ![](/images/barhorange.gif) | 1.58 |
ÍÂ | 3 | ![](/images/barhorange.gif) | 1.58 |
¤ÅÍáÃÁ࿹ԤÍÅ à¡çº | 3 | ![](/images/barhorange.gif) | 1.58 |
ÍÒËÒÃ+ÍѹµÃÒ·ҧ¡ÒÂÀÒ¾ | 3 | ![](/images/barhorange.gif) | 1.58 |
¢Öé¹·ÐàºÕ¹ Í | 3 | ![](/images/barhorange.gif) | 1.58 |
¾ÅÙ¤ÒÇ ¨Ñº | 2 | ![](/images/barhorange.gif) | 1.05 |
ÊÁҾѹÊÁÒ¤ÁÅÙ¡¨éÒ§¢Í§ÃÑ° | 2 | ![](/images/barhorange.gif) | 1.05 |
áι´Õéä´ÃìàÊÕº¡Ñº¤ÍÁáÅéÇäÁè¢Öé¹ | 2 | ![](/images/barhorange.gif) | 1.05 |
¾Åѧ...ÊÙèªÑª¹Ð | 2 | ![](/images/barhorange.gif) | 1.05 |
ÇèÒ¹ªÑ¡Á´ÅÙ¡Â ¢Ç´ÅР35 ºÒ·´ÕäËÁ | 2 | ![](/images/barhorange.gif) | 1.05 |
àª×éÍÊàµÃ»âµ¤çÍ¡¤ÑÊ ¡ÅØèÁºÕ | 2 | ![](/images/barhorange.gif) | 1.05 |
¾.Ã.º.à¤Ã×èͧÁ×Íá¾·Âì ¾.È.2531 | 2 | ![](/images/barhorange.gif) | 1.05 |
áªÁ¾ÙËÁÑ¡ªÕÇÀÒ¾ | 2 | ![](/images/barhorange.gif) | 1.05 |
»ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ ©ºÑº 135 ¾.È. 2539 | 2 | ![](/images/barhorange.gif) | 1.05 |
á͹¹Ò¤ÍÊàÁµÔ¡Êì | 2 | ![](/images/barhorange.gif) | 1.05 |
research colon cancer | 2 | ![](/images/barhorange.gif) | 1.05 |
"assessment of essential drugs selection" | 2 | ![](/images/barhorange.gif) | 1.05 |
Áҵðҹ«ÕÍÔêÇ | 2 | ![](/images/barhorange.gif) | 1.05 |
ÂÒ | 2 | ![](/images/barhorange.gif) | 1.05 |
ÁÍ¡. 235 àÅèÁ 14-2531 ¹ÔÂÒÁÈѾ·ì | 2 | ![](/images/barhorange.gif) | 1.05 |
¾ÃÐÃÒªºÑѵÔÇèÒ´éÇ¡ÒÃãËéàÍ¡ª¹à¢éÒÃèÇÁ§Ò¹ act | 2 | ![](/images/barhorange.gif) | 1.05 |
¤ÇÒÁ˹Òá¹è¹äÎà´ÃµäÅÁì | 2 | ![](/images/barhorange.gif) | 1.05 |
¡ÒõÃǨàÍ¡Åѡɳì¾×ªÊÁعä¾Ã | 2 | ![](/images/barhorange.gif) | 1.05 |
ºÑªÕÃÒª×èÍÇѵ¶ØÍѹµÃÒ ÅèÒÊØ´ | 2 | ![](/images/barhorange.gif) | 1.05 |
¢Ñ鹵͹¡ÒâÖé¹·ÐàºÕ¹ Í | 2 | ![](/images/barhorange.gif) | 1.05 |
á¹Ç·Ò§¡ÒÃÇÔà¤ÃÒÐËì swot ÊÒ¸ÒóÊØ¢ | 1 | ![](/images/barhorange.gif) | 0.53 |
ÊØŵèÒ¹ÃÑ°¡ÅѹµÑ¹ | 1 | ![](/images/barhorange.gif) | 0.53 |
»ÅÒ¡Ãлëͧ ÁҵðҹÍÒËÒÃáÅÐÂÒ | 1 | ![](/images/barhorange.gif) | 0.53 |
sucralose »ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ | 1 | ![](/images/barhorange.gif) | 0.53 |
¡ÇÒÇà¤Ã×Íá´§ ¼Å¢éÒ§à¤Õ§ | 1 | ![](/images/barhorange.gif) | 0.53 |
swot ¡ÒúԹä·Â | 1 | ![](/images/barhorange.gif) | 0.53 |
ʶԵԡÒûèÇÂâäÁ×Íà·éÒ»Ò¡à»×èÍ | 1 | ![](/images/barhorange.gif) | 0.53 |
ÂÒʵÃÕáÁèàÅ×è͹ | 1 | ![](/images/barhorange.gif) | 0.53 |
ÇÕÃСÐÅÑÊ | 1 | ![](/images/barhorange.gif) | 0.53 |
˹͹»ÅÒ¡Ãлëͧ | 1 | ![](/images/barhorange.gif) | 0.53 |
¡ÒûÃСѹ¤Ø³ÀÒ¾ÍÒËÒà | 1 | ![](/images/barhorange.gif) | 0.53 |
¾ÅàÍ¡ . à¡ÉÁªÒµÔ ¹àÃÈàʹÕÂì | 1 | ![](/images/barhorange.gif) | 0.53 |
Êӹѡ§Ò¹»ÃСѹÊØ¢ÀÒ¾ ºÑ¹·Ö¡¢éÍÁÙÅä¢éËÇÑ´äËè | 1 | ![](/images/barhorange.gif) | 0.53 |
âËÂè§àËÔ§ ËÅÍ¡Åǧ | 1 | ![](/images/barhorange.gif) | 0.53 |
ÍѹµÃÒ¨ҡ¡ÒÃãªéÊÒÃà¤ÁÕ·Ò§´éÒ¹à¡ÉµÃ¡ÃÃÁ | 1 | ![](/images/barhorange.gif) | 0.53 |
ÃÒ§ҹ¡ÒÃÇԨѤÇÁ¾Ö§¾Í㨼ÙéºÃÔâÀ¤ | 1 | ![](/images/barhorange.gif) | 0.53 |
ÇÔ¸Õ·Ó¹éÓÊéÁà¡Åç´ËÔÁÐ | 1 | ![](/images/barhorange.gif) | 0.53 |
ä´ÍÍ¡ÇÔ¹ | 1 | ![](/images/barhorange.gif) | 0.53 |
¤èÒáç»ÃШǺ | 1 | ![](/images/barhorange.gif) | 0.53 |
ÁÍ¡.9003 | 1 | ![](/images/barhorange.gif) | 0.53 |
µÅҴ˹ÍäÁé | 1 | ![](/images/barhorange.gif) | 0.53 |
"à¤Ã×èͧÊÓÍҧ㹪ÕÇÔµ»ÃШÓÇѹ" | 1 | ![](/images/barhorange.gif) | 0.53 |
¡ÒÃàµÃÕÂÁÍØ»¡Ã³ì»ÃСͺÍÒËÒà | 1 | ![](/images/barhorange.gif) | 0.53 |
¤ÃÕÁ ÊÓà¾ç§ | 1 | ![](/images/barhorange.gif) | 0.53 |
ceftazidime or ciprofloxacine or augmentin "¡ÒûÃÐàÁÔ¹¡ÒÃãªéÂÒ" | 1 | ![](/images/barhorange.gif) | 0.53 |
¼èͧ¾Ãó µÃÑÂÁ§¤Å¡ÙÅ | 1 | ![](/images/barhorange.gif) | 0.53 |
Êӹѡ¾ÔÁ¾ìâÍà´Õ¹ÊâµÃì future magazine ÇÒ§¨Ó˹èÒ·Õèä˹ | 1 | ![](/images/barhorange.gif) | 0.53 |
§Ùà¢ÕÂÇËÒ§äËÁé ÀÒÉÒÍѧ¡ÄÉ | 1 | ![](/images/barhorange.gif) | 0.53 |
drug system thailand ÃкºÂÒ | 1 | ![](/images/barhorange.gif) | 0.53 |
§Ò¹ÇԨѠÇÔâè¹ì ÈÃÕÍØÌÒþ§Èì | 1 | ![](/images/barhorange.gif) | 0.53 |
àÀÊѪàªÕ§ãËÁè ÊÔ·¸ÔºÑµÃ | 1 | ![](/images/barhorange.gif) | 0.53 |
ª¹Ô´¢Í§ÂÒªÒ | 1 | ![](/images/barhorange.gif) | 0.53 |